Clinical Trial Update: Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating anticoagulation for new-onset post-operative atrial fibrillation after CABG, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Atrial Fibrillation, Stroke | Phase 3 | Status: RECRUITING